Copy number alterations in prostate tumors and disease aggressiveness
Authors:
Open Access
- 2 October 2011
- journal article
- research article
- Published by Wiley in Genes, Chromosomes and Cancer
- Vol. 51 (1) , 66-76
Abstract
Detecting genomic alterations that result in more aggressive prostate cancer may improve clinical treatment and our understanding of the biology underlying this common but complex disease. To this end, we undertook a genome‐wide copy number alterations (CNAs) study of clinicopathological characteristics of 62 prostate tumors using the Illumina 1M single nucleotide polymorphism array. The highest overall frequencies of CNAs were on chromosomes 8q (gains), 8p (loss and copy‐neutral), and 6q (copy‐loss). Combined loss and copy‐neutral events were associated with increasing disease grade (P = 0.03), stage (P = 0.01), and diagnostic prostate specific antigen (PSA) (P = 0.01). Further evaluation of CNAs using gene ontology identified pathways involved with disease aggressiveness. The “regulation of apoptosis” pathway was associated with stage of disease (P = 0.004), while the “reproductive cellular process” pathway was associated with diagnostic PSA (P = 0.00038). Specific genes within these pathways exhibited strong associations with clinical characteristics; for example, in the apoptosis pathway BNIP3L was associated with increasing prostate tumor stage (P = 0.007). These findings confirm known regions of CNAs in prostate cancer and localize additional regions and possible genes (e.g., BNIP3L, WWOX, and GATM) that may help to clarify the genetic basis of prostate cancer aggressiveness.Keywords
This publication has 20 references indexed in Scilit:
- DNA copy number alterations in prostate cancers: A combined analysis of published CGH studiesThe Prostate, 2007
- Genome-wide analysis of allelic imbalance in prostate cancer using the Affymetrix 50K SNP mapping arrayBritish Journal of Cancer, 2007
- TMPRSS2:ERG Fusion-Associated Deletions Provide Insight into the Heterogeneity of Prostate CancerCancer Research, 2006
- Comprehensive assessment of DNA copy number alterations in human prostate cancers using Affymetrix 100K SNP mapping arrayGenes, Chromosomes and Cancer, 2006
- A Role for the WWOX Gene in Prostate CancerCancer Research, 2006
- Aberrant Methylation and Deacetylation of Deleted in Liver Cancer-1 Gene in Prostate Cancer: Potential Clinical ApplicationsClinical Cancer Research, 2006
- Prostate cancer risk from occupational exposure to polycyclic aromatic hydrocarbons interacting with the GSTP1 Ile105Val polymorphismCancer Detection Prevention, 2006
- Frequent somatic mutations of the transcription factor ATBF1 in human prostate cancerNature Genetics, 2005
- Cloning, characterization, and chromosomal localization of a gene frequently deleted in human liver cancer (DLC-1) homologous to rat RhoGAP.1998
- Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization.1997